Objective: This paper sought to review current knowledge about the relationship between substance misuse and early psychosis.
Methods: A literature search was conducted using Medline and restricting the search to articles after 1996. Additional articles were sourced from reference lists of relevant articles.
Results: There is a high prevalence of substance misuse among persons with early psychosis, with cannabis and alcohol featuring prominently. Substance misuse is associated with earlier onset and possibly more positive symptoms, although apparently not with greater cognitive impairment. Cannabis appears to confer an increased likelihood of developing schizophrenia in biologically vulnerable individuals. Amphetamines also cause psychosis which may become chronic, although specific vulnerability to this effect is less well established. Many cases of so-called ‘drug-induced psychosis’ become diagnosed as schizophrenia in later years. Specific intervention programs report positive outcomes with regard to substance misuse and the course of psychosis.
Conclusions: Substance misuse should always be assessed in this patient group, bearing in mind the potential interactive causes of psychopathology. Intervention is of value in improving outcomes.
HambrechtMHafnerH. Substance abuse and the onset of schizophrenia. Biological Psychiatry1996; 40: 1155–1163.
2.
CantwellRBrewenJGlazebrookC. Prevalence of substance misuse in first episode psychosis. British Journal of Psychiatry1999; 174: 150–153.
3.
VerdouxHLiraudFGonzalesBAssensFAbalanFvan OsJ. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatrica Scandinavica1999; 100: 389–395.
4.
Van MastrigtSAddingtonJAddingtonD. Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology2004; 39: 69–72.
5.
AddingtonJAddingtonD. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica2007; 115: 304–309.
6.
LambertMConusPLubmanDI. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavica2005; 112: 141–148.
7.
SimKSwapnaVMythilyS. Psychiatric comorbidity in first-episode psychosis: the Early Psychosis Intervention Program (EPIP) experience. Acta Psychiatrica Scandinavica2004; 109: 23–29.
8.
KorkeilaJASvirskisTHeinimaaM. Substance abuse and related diagnoses in early psychosis. Comprehensive Psychiatry2005; 46: 447–452.
9.
SorbaraFLiraudFAssensFAbalanFVerdouxH. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. European Psychiatry2003; 18: 133–136.
10.
WadeDHarriganSEdwardsJBurgessPMWhelanGMcGorryPD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry2006; 189: 229–234.
11.
BoydellJDeanKDuttaRGiouroukouEFearonPMurrayR. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis. Schizophrenia Research2007; 93: 203–210.
12.
GrechAVan OsJJonesPBLewisSWMurrayRM. Cannabis use and outcome of recent onset psychosis. European Psychiatry2005; 20: 349–353.
13.
VeenNSeltenJ-Pvan der TweelIFellerWGHoekHWKahnRS. Cannabis use and age of onset of schizophrenia. American Journal of Psychiatry2004; 161: 501–506.
14.
BarnesTREMutsatsaSHHuttonSBWattHCJoyceEM. Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry2006; 188: 237–242.
15.
PencerAAddingtonJ. Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience2003; 28: 48–54.
16.
SevySRobinsonDGSollowayS. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica2001; 104: 367–374.
17.
StirlingJLewisSHopkinsRWhiteC. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophrenia Research2005; 75: 135–137.
18.
HambrechtMHafnerH. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Australian and New Zealand Journal of Psychiatry2000; 34: 469–475.
19.
FergussonDMHorwoodLJSwain-CampbellNR. Cannabis dependence and psychotic symptoms in young people. Psychological Medicine2003; 33: 15–21.
20.
VerdouxHGindreCSorbaraFTournierMSwendsenJD. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine2003; 33: 23–32.
21.
MillerPLawrieSMHodgesAClaffertyRCoswayRJohnstoneEC. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Social Psychiatry and Psychiatric Epidemiology2001; 36: 338–342.
22.
PhillipsLJCurryCYungARYuenHPAdlardSMcGorryPD. Cannabis use is not associated with the development of psychosis in an ‘ultra’ high risk group. Australian and New Zealand Journal of Psychiatry2002; 36: 800–806.
23.
ArseneaultLCannonMWittonJMurrayR. Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry2004; 184: 110–117.
24.
ZammitSAllebeckPAndreassonSLundbergILewisG. Self-reported cannabis use as a risk factor for schizophrenia: further analysis of the 1969 Swedish conscript cohort. British Medical Journal1002; 325: 1199–1201.
25.
Van OsJBakMHanssenMBijlRVde GraafRVerdouxH. Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology2002; 156: 319–327.
26.
ArseneaultLCannonMPoultonRMurrayRCaspiAMoffittTE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal2002; 325: 1212–1213.
27.
CaspiAMoffittTECannonM. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry2005; 57: 1117–1127.
28.
McKetinRMcLarenJLubmanDIHidesL. The prevalence of psychotic symptoms among methamphetamine users. Addiction2006; 101: 1473–1478.
29.
DegenhardtLRoxburghABlackE. The epidemiology of methamphetamine use and harm in Australia. Drug and Alcohol Review2008; 27: 243–252.
30.
DarkeSKayeSMcKetinRDuflouJ. Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review2008; 27: 253–262.
31.
ChenC-KLinS-KShamPC. Pre-morbid characteristics and comorbidity of methamphetamine users with and without psychosis. Psychological Medicine2003; 33: 1407–1414.
32.
ChenCKLinSKShamPCBallDLohel-WMurrayRM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. American Journal of Medical Genetics2005; 136: 87–91.
33.
AddingtonJAddingtonD. Effect of substance misuse in early psychosis. British Journal of Psychiatry1998; 172(Suppl. 33)134–136.
34.
ArendtMRosenbergRFoldagerLPertoGMunk-JorgensenP. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry2005; 187: 510–515.
35.
AddingtonJAddingtonD. Impact of an early psychosis program on substance use. Psychiatric Rehabilitation Journal2001; 25: 60–67.
36.
KavanaghDJYoungRWhiteA,. Start Over and Survive: a brief intervention for substance misuse in early psychosis. Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery, GrahamHLCopelloABirchwoodMJMueserKT, Wiley, Chichester2003; 245–258.
37.
KavanaghDJYoungRWhiteA. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review2004; 23: 151–155.
38.
KempRHarrisAVurelESitharthanT. Stop Using Stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007; 15: 490–492.
39.
FarrellySHarrisMGHenryLP. Prevalence and correlates of comorbidity 8 years after a first psychotic episode. Acta Psychiatrica Scandinavica2007; 116: 62–70.
40.
EdwardsJHintonMElkinsKAthanasopoulosO. Cannabis and first-episode psychosis: the CAP Project. Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery, GrahamHLCopelloABirchwoodMJMueserKT. Wiley, Chichester2003; 282–304.
